All posts from Zacks
Zacks in Our Research. Your Success.,

Top Stock Picks for the Week of July 24th

Facebook Inc. FB, operates a social networking website worldwide. This Zacks Rank #1, Strong Buy, stock with a Growth score of ‘A’, has ample growth catalysts. Not the least of which are earnings estimates that continue to rise. A strong balance sheet and significant cash flow also make it attractive for investors. 

Vertex Pharmaceuticals Inc. VRTXdiscovers, develops and markets small molecule drugs that address major unmet medical needs.  This company has two cystic fibrosis drugs in its portfolio with blockbuster potential. The company also has a strong history of beating consensus earnings estimates. It’s not only a Zacks Rank #1, Strong Buy, but has both Growth and Momentum scores of ‘A’.

More Stock News: Tech Opportunity Worth $386 Billion in 2017

From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.                                                                                

Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Facebook, Inc. (FB): Free Stock Analysis Report
Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research